VMP 39116211000001106

Search dm+d | This VMP cannot be matched against our prescribing data.

Name Generic COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials
BNF code 1404000ATAAAAAA
Virtual Therapeutic Moiety COVID-19 vaccine
Basis of preferred name Other
Date of name applicability 10 May 2022
Previous name Generic COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) 5x10,000,000,000 viral particles/0.5ml dose suspension for injection multidose vials
Basis of previous name Other
Reason for name change Other
Prescribing status Never Valid To Prescribe As A VMP
Sugar free
Gluten free
Preservative free
CFC free
Non-availability Actual Products not Available
Non-availability status date 13 Sep 2024
Dose form Discrete
Unit dose form size 0.500
Unit dose form units ml
Unit dose unit of measure dose
Ontology Drug Form & Route
Form & Route suspensioninjection.intramuscular
Dose Form
Formulation Suspension for injection
Drug Route
Route Intramuscular
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Virtual Medicinal Product Packs
Generic COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials 100 dose
Generic COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials 10 dose
Generic COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials 80 dose
Generic COVID-19 Vaccine Vaxzevria (ChAdOx1 S [recombinant]) not less than 2.5x100,000,000 infectious units/0.5ml dose suspension for injection multidose vials 8 dose

dm+d data retrieved from TRUD: release NHSBSA_3.1.0_20250310000001, imported on 11th March 2025 at 03:57:45.

Feedback